171 related articles for article (PubMed ID: 20676026)
1. Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.
Bapat SA; Jin V; Berry N; Balch C; Sharma N; Kurrey N; Zhang S; Fang F; Lan X; Li M; Kennedy B; Bigsby RM; Huang TH; Nephew KP
Epigenetics; 2010; 5(8):716-29. PubMed ID: 20676026
[TBL] [Abstract][Full Text] [Related]
2. Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells.
Chapman-Rothe N; Curry E; Zeller C; Liber D; Stronach E; Gabra H; Ghaem-Maghami S; Brown R
Oncogene; 2013 Sep; 32(38):4586-92. PubMed ID: 23128397
[TBL] [Abstract][Full Text] [Related]
3. Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis.
Curry E; Zeller C; Masrour N; Patten DK; Gallon J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Bowtell DD; Brown R
Cancer Res; 2018 Mar; 78(6):1383-1391. PubMed ID: 29339543
[TBL] [Abstract][Full Text] [Related]
4. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters.
Yoo S; Bieda MC
BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
[TBL] [Abstract][Full Text] [Related]
6. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
Müller I; Wischnewski F; Pantel K; Schwarzenbach H
BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Signatures at the RUNX2-P1 and Sp7 Gene Promoters Control Osteogenic Lineage Commitment of Umbilical Cord-Derived Mesenchymal Stem Cells.
Sepulveda H; Aguilar R; Prieto CP; Bustos F; Aedo S; Lattus J; van Zundert B; Palma V; Montecino M
J Cell Physiol; 2017 Sep; 232(9):2519-2527. PubMed ID: 27689934
[TBL] [Abstract][Full Text] [Related]
8. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.
Coolen MW; Stirzaker C; Song JZ; Statham AL; Kassir Z; Moreno CS; Young AN; Varma V; Speed TP; Cowley M; Lacaze P; Kaplan W; Robinson MD; Clark SJ
Nat Cell Biol; 2010 Mar; 12(3):235-46. PubMed ID: 20173741
[TBL] [Abstract][Full Text] [Related]
9. Histone Modifications and Cancer.
Audia JE; Campbell RM
Cold Spring Harb Perspect Biol; 2016 Apr; 8(4):a019521. PubMed ID: 27037415
[TBL] [Abstract][Full Text] [Related]
10. Oncofetal Epigenetic Bivalency in Breast Cancer Cells: H3K4 and H3K27 Tri-Methylation as a Biomarker for Phenotypic Plasticity.
Messier TL; Boyd JR; Gordon JA; Stein JL; Lian JB; Stein GS
J Cell Physiol; 2016 Nov; 231(11):2474-81. PubMed ID: 26916849
[TBL] [Abstract][Full Text] [Related]
11. JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors.
Kochat V; Equbal Z; Baligar P; Kumar V; Srivastava M; Mukhopadhyay A
PLoS One; 2017; 12(3):e0173977. PubMed ID: 28328977
[TBL] [Abstract][Full Text] [Related]
12. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
13. Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.
Morrison AJ
FEBS J; 2022 Mar; 289(5):1302-1314. PubMed ID: 34036737
[TBL] [Abstract][Full Text] [Related]
14. The role of chromatin, microRNAs, and tumor stem cells in ovarian cancer.
Balch C; Nephew KP
Cancer Biomark; 2010-2011; 8(4-5):203-21. PubMed ID: 22045354
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic complexity during the zebrafish mid-blastula transition.
Andersen IS; Ostrup O; Lindeman LC; Aanes H; Reiner AH; Mathavan S; Aleström P; Collas P
Biochem Biophys Res Commun; 2012 Jan; 417(4):1139-44. PubMed ID: 22209792
[TBL] [Abstract][Full Text] [Related]
16. The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cells.
Chung VY; Tan TZ; Ye J; Huang RL; Lai HC; Kappei D; Wollmann H; Guccione E; Huang RY
Commun Biol; 2019; 2():272. PubMed ID: 31372511
[TBL] [Abstract][Full Text] [Related]
17. The role of histone modifications in epigenetic transitions during normal and perturbed development.
Kubicek S; Schotta G; Lachner M; Sengupta R; Kohlmaier A; Perez-Burgos L; Linderson Y; Martens JH; O'Sullivan RJ; Fodor BD; Yonezawa M; Peters AH; Jenuwein T
Ernst Schering Res Found Workshop; 2006; (57):1-27. PubMed ID: 16568946
[TBL] [Abstract][Full Text] [Related]
18. HMCan: a method for detecting chromatin modifications in cancer samples using ChIP-seq data.
Ashoor H; Hérault A; Kamoun A; Radvanyi F; Bajic VB; Barillot E; Boeva V
Bioinformatics; 2013 Dec; 29(23):2979-86. PubMed ID: 24021381
[TBL] [Abstract][Full Text] [Related]
19. Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications.
Kwon MJ; Kim SS; Choi YL; Jung HS; Balch C; Kim SH; Song YS; Marquez VE; Nephew KP; Shin YK
Carcinogenesis; 2010 Jun; 31(6):974-83. PubMed ID: 20053926
[TBL] [Abstract][Full Text] [Related]
20. Sporadic DUX4 expression in FSHD myocytes is associated with incomplete repression by the PRC2 complex and gain of H3K9 acetylation on the contracted D4Z4 allele.
Haynes P; Bomsztyk K; Miller DG
Epigenetics Chromatin; 2018 Aug; 11(1):47. PubMed ID: 30122154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
